HSBC HOLDINGS PLC

Position in TBPH — Theravance Biopharma, Inc.

CIK 873630 LONDON, X0

Position in TBPH

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$701,200

+$355,496 QoQ

Shares Held

43,204

+133.8% QoQ

Ownership

0.084%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $957,027,307 across 122 Biotechnology names. TBPH ranks #43 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	655,443	$292,681,510
2	REGN	Regeneron Pharmaceuticals, Inc.	323,338	$249,823,869
3	RPRX	Royalty Pharma plc	1,544,018	$74,066,541
4	INCY	Incyte Corp	582,368	$54,812,474
5	ALNY	Alnylam Pharmaceuticals, Inc.	89,619	$29,652,235
6	MRNA	Moderna, Inc.	490,088	$24,896,468
7	INSM	INSMED Inc	116,456	$19,042,883
8	PTCT	Ptc Therapeutics, Inc.	227,059	$15,469,528

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$701,200	43,204	+133.8%	Shares	Defined	2026-04-30
2025-12-31	$345,704	18,477	-62.2%	Shares	Defined	2026-03-20
2025-09-30	$714,188	48,917	-14.5%	Shares	Defined	2025-11-13
2025-06-30	$631,070	57,214	+346.0%	Shares	Defined	2025-08-13
2024-06-30	$108,789	12,829	+23.2%	Shares	Defined	2024-08-12
2021-03-31	$212,508	10,412	-14.2%	Shares	Defined	2021-05-14
2020-12-31	$215,550	12,130	0.0%	Shares	Defined	2021-02-25
2020-09-30	$179,342	12,130	0.0%	Shares	Defined	2020-11-12
2020-06-30	$254,608	12,130	-6.0%	Shares	Defined	2020-08-14
2020-03-31	$298,211	12,904	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.